Skip to content

Clinical trials

Phase 2 Heart Diseases trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 2 Country / region: Israel Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20121
20151
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardurion Pharmaceuticals, Inc.1
Celladon Corporation1
Enopace Biomedical1
Inotek Pharmaceuticals Corporation1
KAI Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases5
Cardiovascular Diseases4
Heart Failure3
Cardiomegaly1
Cardiomyopathies1
Infarction1
Myocardial Infarction1
Myocardial Ischemia1
Pathologic Processes1
Postoperative Complications1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.